The application of 5.0-Tesla non-enhanced MRI in the preoperative assessment of renal tumors.

X Xianda Chen (Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China) S Shengjie Guo J Jian Zhou M Mengdi Zhang G Guixiao Xu (Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China) K Kai Yao (School of Materials Science and Engineering) H Hui Han C Chuan-miao Xie (Sun Yat-sen University Cancer Center, Guangzhou, China) J Jun Wang Z Zhenhua Liu (Shanghai Collaborative Innovation Center of Agri-Seeds, School of Agriculture and Biology, Shanghai Jiao Tong University) K Kangbo Huang (Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China)

Abstract

426 Background: To assess the utility of 5.0-Tesla non-enhanced magnetic resonance imaging (5T NE MRI) for preoperative evaluation of renal tumor patients, particularly with renal insufficiency, as an alternative to contrast-enhanced computed tomography (CECT). Methods: We enrolled participants in a sequential cohort based on their renal status. Initially, eighteen patients with renal insufficiency (glomerular filtration rate < 90 mL/min/1.73 m²) underwent a 5T NE MRI for preoperative assessment. Afterward, 68 patients with normal renal function underwent both 5T NE MRI and CECT preoperatively. Imaging diagnoses, tumor staging, and renal arterial visualization were evaluated. Results: In patients with renal insufficiency, 5T NE MRI correctly identified 16 of 17 (94.1%) renal cell carcinoma (RCC) cases and accurately staged 92.9% of T 1–2 stage RCC (13/14) and 100% of T 3–4 stage RCC (3/3). Among patients with normal renal function, 5T NE MRI demonstrated higher diagnostic accuracy for RCC than CECT (59/59, 100% versus 53/59, 89.8%, p = 0.031) and correctly diagnosed all lipid-poor angiomyolipoma cases (2/2 versus 0/2 on CT). 5T NE MRI provided superior accuracy for identifying 57/57 T 1–2 stage (100%) versus 50/57 (87.7%) on CECT (p = 0.016) with no overstaging, while CECT overstaged 7 cases. Both 5T NE MRI and CECT achieved 100% visualization of grade 3 renal arteries. Conclusions: 5T NE MRI offers high diagnostic accuracy and staging, additionally providing grade 3 vascular visualization. It yields excellent diagnostic performance for renal tumors comparable to CECT, without the need for nephrotoxic contrast or radiation. It is especially beneficial for patients with renal insufficiency as a promising alternative in preoperative evaluation. CECT, n/N (%) 5T NE MRI, n/N (%) P-value Diagnostic Accuracy  RCC 53/59 (89.8) 59/59 (100.0) 0.031  AML 7/9 (77.8) 9/9 (100.0) 0.500  Lipid-poor AML 0/2 2/2 T stage Accuracy  T 1-2 Accordance 50 57 0.016  T 3-4 Accordance 2 2 - Vessel Grade b  Grade ≤3 68 (100.0) 68 (100.0) -  Grade ≥4 61 (88.1) 46 (64.3) <0.001

Article Details

Volume / Issue Vol. 44, Issue 7_suppl
Published March 01, 2026
Pages 426-426
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (11)

X

Xianda Chen

Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China

S

Shengjie Guo

J

Jian Zhou

M

Mengdi Zhang

G

Guixiao Xu

Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China

K

Kai Yao

School of Materials Science and Engineering

H

Hui Han

C

Chuan-miao Xie

Sun Yat-sen University Cancer Center, Guangzhou, China

J

Jun Wang

Z

Zhenhua Liu

Shanghai Collaborative Innovation Center of Agri-Seeds, School of Agriculture and Biology, Shanghai Jiao Tong University

K

Kangbo Huang

Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China